CLDX Celldex Therapeutics, Inc. - Common Stock
$41.97
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$20–$45
87% of range
分析师评级
BUY
22 analysts
目标价
$58
+38% upside
P/E (TTM)
-10.8
ROE
-43.8%
净利润率
-16748.0%
CLDX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$41.97
市值
$2.79B
P/E (TTM)
-10.8
每股收益 (TTM)
$-3.90
营收 (TTM)
$2M
股息收益率
—
ROE
-43.8%
负债/权益
—
52周区间
$20 – $45
CLDX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$2M
2016-12-31
→
2025-12-31
EPS
$-3.90
2019-12-31
→
2025-12-31
自由现金流
$-214M
2016-12-31
→
2025-12-31
利润率
-16748.0%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CLDX
同行中位数
P/E (TTM)
-10.8
—
P/S (TTM) (市销率 (TTM))
1807.6
18.3
P/B (市净率)
5.3
3.3
Price / FCF (股价/自由现金流)
-13.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CLDX
同行中位数
Operating Margin (营业利润率)
-18599.8%
—
Net Profit Margin (净利润率)
-16748.0%
-180.4%
ROA
-37.6%
-36.2%
ROE
-43.8%
-43.7%
ROIC
-54.5%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CLDX
同行中位数
Current Ratio (流动比率)
10.5
9.7
Quick Ratio (速动比率)
10.2
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CLDX
同行中位数
Revenue YoY (营收同比增长)
-78.0%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-13.1%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-26.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CLDX
同行中位数
CLDX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
22 位分析师
- 强烈买入 7 31.8%
- 买入 13 59.1%
- 持有 2 9.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
15 位分析师 · 2026-08-14
中位数
$56.00
现在
$41.97
最低
$38.00
最高
$100.00
中位数目标
$56.00
+33.4%
平均目标
$58.07
+38.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.03%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.94 | $-1.08 | 0.14% |
| 2026年3月31日 | $-1.18 | $-1.16 | -0.02% |
| 2025年12月31日 | $-1.22 | $-1.03 | -0.19% |
| 2025年9月30日 | $-1.01 | $-0.92 | -0.09% |
| 2025年6月30日 | $-0.85 | $-0.87 | 0.02% |
| 2025年3月31日 | $-0.81 | $-0.77 | -0.04% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Cost of Revenue | $200.0K | $200.0K | $300.0K | $100.0K | $100.0K | $200.0K | $100.0K | $700.0K | $700.0K | $2M | · | · | |
| R&D Expense | $245M | $164M | $118M | $82M | $53M | $43M | $43M | $66M | $96M | $103M | $100M | $104M | |
| SG&A Expense | $44M | $39M | $31M | $27M | $20M | $14M | $15M | $19M | $25M | $36M | $34M | $21M | |
| Operating Expenses | $289M | $202M | $161M | $118M | $76M | $71M | $59M | $166M | $134M | $140M | $135M | $126M | |
| Operating Income | $-287M | $-195M | $-155M | $-115M | $-71M | $-63M | $-55M | $-156M | $-122M | $-133M | $-130M | $-122M | |
| Pretax Income | $-259M | $-158M | $-141M | $-112M | $-71M | $-61M | $-51M | $-152M | $-117M | $-129M | $-127M | · | |
| Income Tax | $0 | $0 | $0 | · | $-227.0K | $-1M | · | $-765.0K | $-24M | · | · | · | |
| Net Income | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| EPS (Basic) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| EPS (Diluted) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| Shares (Basic) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| Shares (Diluted) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| EBITDA | $-284M | $-192M | $-152M | $-112M | $-68M | $-59M | $-50M | $-153M | $-117M | $-130M | $-127M | $-120M |
资产负债表 24
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $28M | $35M | $29M | $39M | $44M | $11M | $24M | $40M | $42M | $72M | $28M | |
| Short-term Investments | $490M | $697M | $389M | $276M | $369M | $151M | $53M | $70M | · | · | · | · | |
| Prepaid Expense | $14M | $21M | $5M | $12M | $2M | $2M | $1M | $2M | $3M | $4M | $4M | $4M | |
| Current Assets | $535M | $747M | $432M | $318M | $411M | $198M | $67M | $99M | $145M | $196M | $295M | $205M | |
| PP&E (Net) | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $6M | $10M | $13M | $11M | $11M | |
| PP&E (Gross) | $29M | $28M | $26M | $25M | $25M | $25M | $32M | $32M | $34M | $33M | $29M | $25M | |
| Accum. Depreciation | $24M | $23M | $22M | $22M | $21M | $21M | $28M | $26M | $24M | $20M | $17M | $14M | |
| Goodwill | · | · | · | · | · | · | · | · | $91M | $91M | $9M | $9M | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $31M | $49M | $49M | $68M | $81M | $21M | $22M | |
| Other Non-current Assets | $13M | $10M | $107.0K | $104.0K | $104.0K | $41.0K | $41.0K | $2M | $2M | $2M | $1M | $2M | |
| Total Assets | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Accounts Payable | $1M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $47M | $34M | $22M | $13M | $12M | $8M | $6M | $7M | $19M | $29M | $24M | $19M | |
| Current Liabilities | $51M | $40M | $31M | $19M | $17M | $14M | $12M | $13M | $28M | $35M | $30M | $24M | |
| Capital Leases | $784.0K | $2M | $928.0K | $3M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Other Non-current Liabilities | $4M | $3M | $4M | $5M | $7M | $10M | $16M | $19M | $52M | $83M | $17M | $12M | |
| Total Liabilities | $56M | $45M | $36M | $27M | $25M | $26M | $29M | $32M | $79M | $118M | $47M | $36M | |
| Common Stock | $67.0K | $66.0K | $56.0K | $47.0K | $47.0K | $40.0K | $17.0K | $12.0K | $9.0K | $121.0K | $99.0K | $90.0K | |
| Retained Earnings | $-1.81B | $-1.56B | $-1.40B | $-1.26B | $-1.14B | $-1.07B | $-1.01B | $-962M | $-813M | $-719M | $-591M | $-464M | |
| AOCI | $4M | $3M | $3M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stockholders' Equity | $527M | $747M | $429M | $326M | $419M | $209M | $94M | $124M | $236M | $265M | $290M | $212M | |
| Liabilities + Equity | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Shares Outstanding | 66,549,442 | 66,374,549 | 55,883,377 | 47,200,695 | 46,730,198 | 39,603,771 | 16,972,077 | 11,957,635 | 9,234,693 | 120,516,654 | 98,685,595 | 89,592,779 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Stock-based Comp | $36M | $34M | $24M | $16M | $9M | $4M | $5M | $8M | $12M | $15M | $13M | $7M | |
| Amort. of Intangibles | · | · | · | · | · | $0 | $0 | $224.0K | $896.0K | $997.0K | $1M | $1M | |
| Other Non-cash | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-211M | $-158M | $-107M | $-104M | $-61M | $-40M | $-46M | $-75M | $-100M | $-113M | $-99M | $-102M | |
| CapEx | $3M | $2M | $2M | $2M | $1M | $2M | $731.0K | $813.0K | $2M | $3M | $5M | $2M | |
| Investing Cash Flow | $209M | $-290M | $-106M | $90M | $-216M | $-98M | $17M | $30M | $46M | $69M | $-50M | · | |
| Stock Issued | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Net Stock Activity | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Financing Cash Flow | $2M | $441M | $218M | $4M | $272M | $171M | $16M | $29M | $51M | $14M | $193M | · | |
| Net Change in Cash | $515.0K | $-6M | $5M | $-10M | $-5M | $33M | $-13M | $-16M | $-2M | $-30M | $44M | $-141M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-214M | $-160M | $-109M | $-106M | $-62M | $-42M | $-47M | $-76M | $-102M | $-116M | $-104M | $-103M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% | -1540.2% | · | -953.7% | -1958.7% | -2363.9% | -3414.1% | |
| Net Margin | -16748.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -16748.0% | -2248.8% | -2054.8% | -4765.6% | -1520.9% | -821.6% | -1424.0% | · | -920.6% | · | · | · | |
| EBITDA Margin | -18381.0% | -2733.6% | -2201.6% | -4766.1% | -1465.8% | -801.1% | -1404.2% | · | -919.0% | -1913.1% | -2309.2% | -3347.5% | |
| ROA | -37.6% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -43.8% | · | · | · | · | · | · | · | · | · | · | · | |
| ROIC | -54.5% | · | · | · | -16.9% | -29.7% | · | -125.5% | -40.8% | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 | 13.9 | 5.7 | 7.9 | 5.2 | 5.6 | 9.8 | 8.4 | |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 | 13.7 | 5.5 | 1.9 | 1.5 | 1.2 | 2.4 | 1.1 |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -78.0% | 2.0% | 192.0% | -49.3% | -37.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -13.1% | 14.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Net Income TTM | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| Market Cap | $1.81B | $1.68B | $2.22B | $2.10B | $1.81B | $694M | $38M | $36M | $5.90B | $6.40B | $23.21B | $24.53B | |
| P/E | -7.0 | -10.3 | -13.6 | -18.6 | -23.6 | -8.7 | -0.6 | · | · | · | · | · | |
| P/S | 1169.9 | 238.9 | 322.0 | 892.5 | 388.2 | 93.5 | 10.6 | 3.8 | 463.1 | 943.0 | 4235.6 | 6839.4 | |
| P/B | 3.4 | 2.2 | 5.2 | 6.4 | 4.3 | 3.3 | 0.4 | 0.3 | 25.0 | 24.1 | 80.0 | 115.9 | |
| P / Tangible Book | 3.6 | 2.3 | 5.5 | 7.0 | 4.6 | 3.9 | · | · | · | · | · | · | |
| P / Cash Flow | -8.6 | -10.6 | -20.7 | -20.3 | -29.6 | -17.2 | -0.8 | -0.5 | -59.1 | -56.6 | -234.7 | -241.5 | |
| P / FCF | -8.5 | -10.5 | -20.3 | -19.9 | -29.0 | -16.5 | -0.8 | -0.5 | -58.0 | -55.3 | -223.7 | -237.0 | |
| Earnings Yield | -14.4% | -9.7% | -7.4% | -5.4% | -4.2% | -11.5% | -157.4% | · | · | · | · | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.0K | $15.0K | $121.0K | $0 | $730.0K | $695.0K | $1M | $3M | $2M | $156.0K | $2M | $268.0K | $967.0K | $2M | $407.0K | $163.0K | |
| R&D Expense | $68M | $73M | $75M | $63M | $54M | $53M | $47M | $45M | $40M | $32M | $35M | $26M | $27M | $23M | $22M | $21M | |
| SG&A Expense | $13M | $11M | $12M | $11M | $10M | $11M | $10M | $10M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $81M | $84M | $87M | $74M | $65M | $63M | $57M | $55M | $49M | $41M | $43M | $33M | $33M | $29M | $28M | $37M | |
| Operating Income | $-81M | $-84M | $-87M | $-74M | $-64M | $-63M | $-56M | $-52M | $-46M | $-41M | $-41M | $-33M | $-32M | $-28M | $-28M | $-36M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | $-27M | $-36M | |
| Net Income | $-74M | $-79M | $-81M | $-67M | $-57M | $-54M | $-47M | $-42M | $-36M | $-33M | · | · | · | · | · | · | |
| EPS (Basic) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| EPS (Diluted) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| Shares (Basic) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| Shares (Diluted) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| EBITDA | $-81M | · | · | $-74M | $-64M | $-62M | · | $-52M | $-46M | $-40M | $-41M | $-33M | $-32M | · | $-28M | $-36M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $29M | $36M | $23M | $17M | $28M | $36M | $43M | $115M | $21M | $28M | $54M | · | $19M | $28M | |
| Short-term Investments | $670M | $416M | $490M | $547M | $607M | $656M | $697M | $720M | $760M | $709M | $214M | $224M | $224M | · | $305M | $328M | |
| Prepaid Expense | $7M | $8M | $14M | $21M | $18M | $19M | $21M | $22M | $8M | $9M | $10M | $12M | $10M | · | $11M | $11M | |
| Current Assets | $725M | $459M | $535M | $604M | $648M | $694M | $747M | $779M | $812M | $835M | $246M | $265M | $290M | · | $335M | $368M | |
| PP&E (Net) | $10M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | |
| PP&E (Gross) | · | · | $29M | · | · | · | $28M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $24M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | $27M | $27M | |
| Other Non-current Assets | $15M | $15M | $13M | $9M | $9M | $10M | $10M | $10M | $107.0K | $107.0K | $107.0K | $107.0K | $104.0K | · | $104.0K | $104.0K | |
| Total Assets | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Accounts Payable | $15M | $10M | $1M | $4M | $2M | $3M | $3M | $1M | $4M | $3M | $4M | $881.0K | $3M | · | $2M | $902.0K | |
| Accrued Liabilities | $44M | $38M | $47M | $40M | $28M | $25M | $34M | $28M | $19M | $18M | $18M | $12M | $9M | · | $11M | $11M | |
| Current Liabilities | $61M | $51M | $51M | $46M | $33M | $32M | $40M | $32M | $28M | $26M | $28M | $16M | $15M | · | $16M | $30M | |
| Capital Leases | $3M | $443.0K | $784.0K | $1M | $1M | $2M | $2M | $2M | $796.0K | $470.0K | $1M | $2M | $2M | · | $2M | $3M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | · | $5M | $5M | |
| Total Liabilities | $68M | $55M | $56M | $50M | $37M | $36M | $45M | $37M | $32M | $30M | $34M | $22M | $22M | · | $24M | $38M | |
| Common Stock | $79.0K | $67.0K | $67.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $47.0K | $47.0K | $47.0K | · | $47.0K | $47.0K | |
| Retained Earnings | $-1.97B | $-1.89B | $-1.81B | $-1.73B | $-1.67B | $-1.61B | $-1.56B | $-1.51B | $-1.47B | $-1.43B | $-1.35B | $-1.32B | $-1.29B | · | $-1.23B | $-1.20B | |
| AOCI | $1M | $3M | $4M | $4M | $3M | $4M | $3M | $5M | $2M | $2M | $2M | $2M | $2M | · | $-112.0K | $-417.0K | |
| Stockholders' Equity | $715M | $456M | $527M | $598M | $655M | $703M | $747M | $786M | $814M | $839M | $247M | $278M | $303M | $326M | $345M | $365M | |
| Liabilities + Equity | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Shares Outstanding | 78,500,173 | 66,568,971 | 66,549,442 | 66,446,846 | 66,394,241 | 66,384,191 | 66,374,549 | 66,344,236 | 66,280,667 | 65,910,548 | 47,264,197 | 47,253,813 | 47,244,681 | · | 47,096,063 | 46,764,703 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $902.0K | $854.0K | $816.0K | $824.0K | $873.0K | $867.0K | $819.0K | $786.0K | $797.0K | $775.0K | $767.0K | $756.0K | $726.0K | $673.0K | $671.0K | $741.0K | |
| Stock-based Comp | $8M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $8M | $7M | $7M | $5M | $4M | $5M | $4M | $3M | |
| Operating Cash Flow | $-57M | $-66M | $-64M | $-49M | $-44M | $-54M | $-32M | $-55M | $-29M | $-41M | $-19M | $-27M | $-29M | $-22M | $-35M | $-22M | |
| CapEx | $3M | $2M | $1M | $440.0K | $728.0K | $265.0K | $756.0K | $545.0K | $274.0K | $344.0K | $157.0K | $410.0K | $585.0K | $235.0K | $345.0K | $673.0K | |
| Investing Cash Flow | $-256M | $72M | $55M | $61M | $50M | $43M | $24M | $48M | $-47M | $-315M | $12M | $1M | $53M | $31M | $23M | $25M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $432M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $432M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $327.0K | $1M | $774.0K | $63.0K | $202.0K | $386.0K | $1M | $4M | $436M | $257.0K | $133.0K | $694.0K | $1M | $2M | $71.0K | |
| Net Change in Cash | $12M | $7M | $-7M | $13M | $6M | $-11M | $-8M | $-6M | $-72M | $80M | $-7M | $-26M | $25M | $11M | $-10M | $3M | |
| Free Cash Flow | · | · | · | · | · | $-55M | · | · | · | $-41M | · | · | $-29M | · | · | · |
盈利能力 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -366468.2% | · | · | · | -8747.5% | -9027.2% | · | -1633.5% | -1854.2% | -26030.8% | -2718.5% | -12389.9% | -3357.9% | · | -6804.9% | -22328.8% | |
| Net Margin | -334104.6% | · | · | · | -7753.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -6580.8% | -22088.3% | |
| EBITDA Margin | -366468.2% | · | · | · | -8747.5% | -8902.5% | · | -1633.5% | -1854.2% | -25534.0% | -2718.5% | -12389.9% | -3282.8% | · | -6804.9% | -22328.8% | |
| ROA | -10.0% | · | · | -9.1% | -7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -10.7% | · | · | -9.7% | -7.7% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | · | 13.0 | 19.7 | 21.7 | · | 24.3 | 29.4 | 31.8 | 8.8 | 16.9 | 19.0 | · | 20.5 | 12.3 | |
| Quick Ratio | 11.7 | · | · | 12.6 | 19.1 | 21.0 | · | 23.6 | 29.0 | 31.3 | 8.5 | 16.2 | 18.3 | · | 19.9 | 11.9 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $7M | $7M | $7M | · | $7M | $4M | $3M | $3M | $2M | $2M | · | $897.0K | $4M | |
| Net Income TTM | $-276M | $-256M | · | $-220M | $-188M | $-165M | · | · | · | · | · | · | · | · | · | · | |
| Market Cap | $2.92B | · | · | $1.72B | $1.35B | $1.20B | · | $2.26B | $2.45B | $2.77B | $1.30B | $1.60B | $1.70B | · | $1.32B | $1.26B | |
| P/E | -9.3 | -8.2 | · | -7.8 | -7.2 | -7.1 | · | -13.3 | -14.5 | -15.9 | -10.4 | -13.0 | -14.7 | · | -12.3 | -13.2 | |
| P/S | · | · | · | 241.6 | 189.9 | 184.2 | · | 306.3 | 552.6 | 951.3 | 411.7 | 888.3 | 993.5 | · | 1475.9 | 317.6 | |
| P/B | 4.1 | · | · | 2.9 | 2.1 | 1.7 | · | 2.9 | 3.0 | 3.3 | 5.3 | 5.8 | 5.6 | · | 3.8 | 3.5 | |
| P / Tangible Book | 4.2 | 4.9 | · | 3.0 | 2.2 | 1.8 | · | 3.0 | 3.1 | 3.4 | 5.9 | 6.4 | 6.2 | · | 4.2 | 3.7 | |
| P / Cash Flow | · | · | · | · | · | -22.2 | · | · | · | -68.1 | · | · | -59.5 | · | · | · | |
| P / FCF | · | · | · | · | · | -22.1 | · | · | · | -67.5 | · | · | -58.3 | · | · | · | |
| Earnings Yield | -10.7% | -12.1% | · | -12.8% | -14.0% | -14.1% | · | -7.5% | -6.9% | -6.3% | -9.6% | -7.7% | -6.8% | · | -8.1% | -7.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $2M | $7M | $7M | $2M | $5M |
| 营业利润率 % | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% |
| 净收入 | $-259M | $-158M | $-141M | — | — |
| 稀释后每股收益 (EPS) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 |
| 速动比率 | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-214M | $-160M | $-109M | $-106M | $-62M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 277 家申报者 · $2.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 62 (+2 与上一季度对比) | 20 (+7 与上一季度对比) | 99 (+31 与上一季度对比) | 56 (+1 与上一季度对比) | +15.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $312415309 | 8396004 | 12.07% | 股份 |
| Kynam Capital Management, LP | $198065407 | 5322908 | 7.65% | 股份 |
| STATE STREET CORP | $145134889 | 3900427 | 5.61% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $128926362 | 3464831 | 4.98% | 股份 |
| Deep Track Capital, LP | $109365809 | 2939151 | 4.22% | 股份 |
| VANGUARD GROUP INC | $95540813 | 3517703 | 3.69% | 股份 |
| FMR LLC | $87111215 | 2341070 | 3.36% | 股份 |
| Logos Global Management LP | $78141000 | 2100000 | 3.02% | 股份 |
| Eversept Partners, LP | $66454865 | 1785941 | 2.57% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $64373504 | 1729584 | 2.49% | 股份 |
| Commodore Capital LP | $50233500 | 1350000 | 1.94% | 股份 |
| Bellevue Group AG | $44652000 | 1200000 | 1.72% | 股份 |
| BAKER BROS. ADVISORS LP | $44004955 | 1182611 | 1.70% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $43564984 | 1170787 | 1.68% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $38787594 | 1042395 | 1.50% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $38586770 | 1037000 | 1.49% | 股份 |
| NOVO HOLDINGS A/S | $38140250 | 1025000 | 1.47% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $37326505 | 1003131 | 1.44% | 股份 |
| Elmind Capital, LP | $36837900 | 990000 | 1.42% | 股份 |
| Driehaus Capital Management LLC | $36817137 | 989442 | 1.42% | 股份 |
| Fisher Asset Management, LLC | $36677040 | 985677 | 1.42% | 股份 |
| Pictet Asset Management Holding SA | $34136752 | 917408 | 1.32% | 股份 |
| Foresite Capital Management VI LLC | $32734121 | 879713 | 1.26% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32132175 | 863536 | 1.24% | 股份 |
| GOLDMAN SACHS GROUP INC | $31451827 | 845252 | 1.21% | 股份 |
| Assenagon Asset Management S.A. | $29347378 | 788696 | 1.13% | 股份 |
| Woodline Partners LP | $26077884 | 700830 | 1.01% | 股份 |
| Affinity Asset Advisors, LLC | $26047000 | 700000 | 1.01% | 股份 |
| Rock Springs Capital Management LP | $26015223 | 699146 | 1.00% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $24604554 | 661235 | 0.95% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24408048 | 655954 | 0.94% | 股份 |
| ALGERT GLOBAL LLC | $24105978 | 647836 | 0.93% | 股份 |
| ADAR1 Capital Management, LLC | $23053158 | 619542 | 0.89% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $21304139 | 572538 | 0.82% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $20576125 | 552973 | 0.79% | 股份 |
| 5AM Venture Management, LLC | $18503417 | 497270 | 0.71% | 股份 |
| FEDERATED HERMES, INC. | $18340549 | 492893 | 0.71% | 股份 |
| Candriam S.C.A. | $17885437 | 481125 | 0.69% | 股份 |
| Ikarian Capital, LLC | $17804985 | 478500 | 0.69% | 股份 |
| BRAIDWELL LP | $16247598 | 436646 | 0.63% | 股份 |
| Redmile Group, LLC | $16146200 | 433921 | 0.62% | 股份 |
| CITIGROUP INC | $14891144 | 400192 | 0.58% | 股份 |
| Palo Alto Investors LP | $14878642 | 399856 | 0.57% | 股份 |
| TSP Capital Management Group, LLC | $13809638 | 371127 | 0.53% | 股份 |
| PFM Health Sciences, LP | $12753765 | 342751 | 0.49% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $12738025 | 342328 | 0.49% | 股份 |
| SEGALL BRYANT & HAMILL, LLC | $12513388 | 336291 | 0.48% | 股份 |
| Tetragon Partners GP Ltd | $10807310 | 290441 | 0.42% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $10700963 | 287583 | 0.41% | 股份 |
| GordonMD Global Investments LP | $10408381 | 279720 | 0.40% | 股份 |
| BANK OF AMERICA CORP /DE/ | $9518951 | 255817 | 0.37% | 股份 |
| SummitTX Capital, L.P. | $9487024 | 254959 | 0.37% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $8962698 | 240868 | 0.35% | 股份 |
| Rosalind Advisors, Inc. | $7442000 | 200000 | 0.29% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $7285273 | 195788 | 0.28% | 股份 |
| Corient Private Wealth LP | $6925155 | 186110 | 0.27% | 股份 |
| Trexquant Investment LP | $6866138 | 184524 | 0.27% | 股份 |
| Mirador Capital Partners LP | $6737019 | 181054 | 0.26% | 股份 |
| STEMPOINT CAPITAL LP | $6638711 | 178412 | 0.26% | 股份 |
| BlackRock, Inc. | $6469963 | 173877 | 0.25% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6422446 | 172600 | 0.25% | 买入期权 |
| Cinctive Capital Management LP | $5419153 | 145637 | 0.21% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $5211781 | 140064 | 0.20% | 股份 |
| FIRST TRUST ADVISORS LP | $5160357 | 138682 | 0.20% | 股份 |
| Swiss National Bank | $5023350 | 135000 | 0.19% | 股份 |
| MONTANOVA CAPITAL, LLC | $4513461 | 121297 | 0.17% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $4481126 | 120428 | 0.17% | 股份 |
| Point72 Asset Management, L.P. | $4361645 | 117217 | 0.17% | 股份 |
| Ikarian Capital, LLC | $4241940 | 114000 | 0.16% | 卖出期权 |
| RHUMBLINE ADVISERS | $3905662 | 104963 | 0.15% | 股份 |
| Propel Bio Management, LLC | $3858491 | 103695 | 0.15% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3754489 | 100900 | 0.15% | 卖出期权 |
| Integral Health Asset Management, LLC | $3721000 | 100000 | 0.14% | 股份 |
| DEUTSCHE BANK AG\ | $3601705 | 96794 | 0.14% | 股份 |
| Odyssean, LLC | $3537517 | 95069 | 0.14% | 股份 |
| Caption Management, LLC | $3348900 | 90000 | 0.13% | 卖出期权 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3324267 | 89338 | 0.13% | 股份 |
| HighVista Strategies LLC | $3235930 | 86964 | 0.12% | 股份 |
| DIADEMA PARTNERS LP | $3200060 | 86000 | 0.12% | 卖出期权 |
| AXA Investment Managers S.A. | $3138704 | 121326 | 0.12% | 股份 |
| Bank of New York Mellon Corp | $3020782 | 81182 | 0.12% | 股份 |
| PDT Partners, LLC | $3010252 | 80899 | 0.12% | 股份 |
| TD Asset Management Inc | $2951720 | 79326 | 0.11% | 股份 |
| ALPS ADVISORS INC | $2945730 | 79165 | 0.11% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $2811661 | 88640 | 0.11% | 股份 |
| XTX Topco Ltd | $2795773 | 75135 | 0.11% | 股份 |
| Seven Fleet Capital Management LP | $2610802 | 70164 | 0.10% | 股份 |
| Birchview Capital, LP | $2600979 | 69900 | 0.10% | 股份 |
| Quantinno Capital Management LP | $2569276 | 69048 | 0.10% | 股份 |
| DAFNA Capital Management LLC | $2549555 | 68518 | 0.10% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2525864 | 79630 | 0.10% | 股份 |
| Man Group plc | $2362984 | 63504 | 0.09% | 股份 |
| Rafferty Asset Management, LLC | $2089602 | 56157 | 0.08% | 股份 |
| Caption Management, LLC | $2072597 | 55700 | 0.08% | 股份 |
| Simplify Asset Management Inc. | $1977116 | 53134 | 0.08% | 股份 |
| DIADEMA PARTNERS LP | $1893989 | 50900 | 0.07% | 买入期权 |
| Burkehill Global Management, LP | $1860500 | 50000 | 0.07% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $1860500 | 50000 | 0.07% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1850491 | 49731 | 0.07% | 股份 |
| MetLife Investment Management, LLC | $1694060 | 45527 | 0.07% | 股份 |
公司内部人士 49 位内幕人士 · 19 位高管 · 23 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Anthony S Marucci | PRESIDENT & CEO | 2026年6月25日 A | 27231 | 0 | 0 | $0 |
| Una S Ryan | President & CEO | 2008年3月7日 A | 899213 | 0 | 0 | $0 |
| Samuel Bates Martin | SVP AND CFO | 2026年6月25日 A | 24378 | 0 | 0 | $0 |
| Avery W Catlin | Sr. VP & CFO | 2016年9月2日 M | 83586 | 0 | 0 | $0 |
| Teri L Lawver | SVP & Chief Commercial Officer | 2026年6月25日 A | — | 0 | 0 | $0 |
| Freddy A. Jimenez | SVP & GENERAL COUNSEL | 2026年6月25日 A | 430 | 0 | 0 | $0 |
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | 2026年6月25日 A | 11247 | 0 | 0 | $0 |
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | 2026年6月25日 A | 408 | 0 | 0 | $0 |
| Elizabeth Crowley | SR. VP & CPDO | 2026年6月25日 A | 4726 | 0 | 0 | $0 |
| Diane C. Young | SVP, CHIEF MEDICAL OFFICER | 2026年6月25日 A | 2115 | 0 | 0 | $0 |
| Tibor Keler | EXECUTIVE VP & CSO | 2026年6月25日 A | 7357 | 0 | 0 | $0 |
| Ronald Pepin | SR. VP & CBO | 2026年6月25日 A | 20097 | 0 | 0 | $0 |
| Richard M. Wright | Sr. VP & CCO | 2021年6月17日 A | 208 | 0 | 0 | $0 |
| Theresa Lavallee | SVP, Reg.& Precision Medicine | 2016年12月14日 A | — | 0 | 0 | $0 |
| Ronald C Newbold | Sr. VP, Business Dev. | 2009年1月6日 A | 5868 | 0 | 0 | $0 |
| Henry C Marsh JR | V.P. Research | 2008年3月7日 M | — | 0 | 0 | $0 |
| Ronald W Ellis | Sr VP R&D | 2007年1月5日 A | — | 0 | 0 | $0 |
| Michael E Furlong | Sr. Dir. Bus. Development | 2005年7月1日 L | 1500 | 0 | 0 | $0 |
| Alistair Wheeler | V.P. Medical Affairs | 2004年1月2日 A | — | 0 | 0 | $0 |
| Denice Torres | 董事 | 2026年6月25日 A | — | 0 | 0 | $0 |
| Rita Jain | 董事 | 2026年6月25日 A | — | 0 | 0 | $0 |
| Garry Arthur Neil | 董事 | 2026年6月25日 A | — | 0 | 0 | $0 |
| Cheryl Cohen | 董事 | 2026年6月25日 A | — | 0 | 0 | $0 |
| Keith L Brownlie | 董事 | 2026年6月25日 A | 10000 | 0 | 0 | $0 |
| Herbert J Conrad | 董事 | 2026年6月25日 A | 38500 | 0 | 0 | $0 |
| James J Marino | 董事 | 2026年6月25日 A | 12704 | 0 | 0 | $0 |
| Harry Penner JR | 董事 | 2026年6月25日 A | 41916 | 0 | 0 | $0 |
| Karen Shoos Lipton | 董事 | 2021年6月17日 A | 41833 | 0 | 0 | $0 |
| Gerald Mcmahon PhD | 董事 | 2018年12月3日 F | 180697 | 0 | 0 | $0 |
| Larry Ellberger | 董事 | 2018年6月13日 A | 73500 | 0 | 0 | $0 |
| Richard Van Den Broek | 董事 | 2016年6月8日 A | 233500 | 0 | 0 | $0 |
| Timothy M Shannon | 董事 | 2014年6月4日 A | 83212 | 0 | 0 | $0 |
| Rajesh R Parekh | 董事 | 2010年9月22日 A | 2000 | 0 | 0 | $0 |
| Charles R Schaller | 董事 | 2010年9月9日 P | 5000 | 0 | 0 | $0 |
| Alf A Lindberg | 董事 | 2007年5月24日 A | — | 0 | 0 | $0 |
| Francis R Cano | 董事 | 2007年5月24日 A | — | 0 | 0 | $0 |
| Peter A Sears | 董事 | 2007年5月24日 A | 72739 | 0 | 0 | $0 |
| Barrie J Ward | 董事 | 2006年5月25日 A | 367915 | 0 | 0 | $0 |
| PDI INC | 董事 | 2005年5月26日 A | — | 0 | 0 | $0 |
| Frederick W Kyle | 董事 | 2004年5月13日 C | 7000 | 0 | 0 | $0 |
| MEDAREX INC | 10% 所有者 | 2009年6月24日 S | 2960848 | 0 | 0 | $0 |
| Lorantis Holdings LTD | 10% 所有者 | 2008年4月7日 J | 0 | 0 | 0 | $0 |
| Thomas Andrew Davis | — | 2017年6月15日 A | 1011 | 0 | 0 | $0 |
| George Elston | — | 2016年6月8日 A | 28500 | 0 | 0 | $0 |
| Taha Keilani | — | 2008年3月7日 A | 2000 | 0 | 0 | $0 |
| Paula R Freeman | — | 2008年3月7日 M | 2955 | 0 | 0 | $0 |
| Michael Timothy Cooke | — | 2007年1月5日 A | — | 0 | 0 | $0 |
| Mary Nicholson | — | 2005年1月3日 A | 500 | 0 | 0 | $0 |
| Anthony Helstosky | — | 2004年1月6日 C | 6000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Medarex, Inc. I.R.S. Employer Identification Number ×3 申报 | 2009年6月26日 | — | 初始申报 | — | SEC |
| Lorantis Holdings Limited ×2 申报 | 2008年5月12日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 50 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1.33% | 68615 NS | 2026年5月31日 | N-PORT |
| BBC · ETFis Series Trust I | 0.88% | 10032 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.44% | 70017 NS | 2026年4月30日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund ... | 0.23% | 3856 NS | 2026年5月31日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.23% | 73629 NS | 2026年4月30日 | N-PORT |
| IWO · iShares Trust | 0.16% | 576359 SH | 2026年8月8日 | 每日 |
| NUSC · Nushares ETF Trust | 0.16% | 62064 NS | 2026年4月30日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.14% | 67853 SH | 2026年8月8日 | 每日 |
| FFSM · FIDELITY COVINGTON TRUST | 0.13% | 51835 NS | 2026年4月30日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.12% | 43658 NS | 2026年4月30日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.12% | 8106 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.11% | 24795 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.10% | 1997393 SH | 2026年8月8日 | 每日 |
| SMMV · iShares Trust | 0.09% | 6577 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.09% | 449534 SH | 2026年8月8日 | 每日 |
| ISCV · iShares Trust | 0.08% | 14142 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.08% | 32806 NS | 2026年4月30日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.07% | 51058 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.06% | 44111 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.06% | 3561 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 368761 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.05% | 204021 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.05% | 6865 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.04% | 2846 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 12901 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.04% | 201834 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.04% | 137013 SH | 2026年8月8日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 30973 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.04% | 2786 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 897276 SH | 2026年8月8日 | 每日 |
| WSML · iShares Trust | 0.03% | 4615 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.03% | 2818 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 6539 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2668 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 71 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 7780 NS | 2026年4月30日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 26307 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 4620 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 753 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 79390 NS | 2026年4月30日 | N-PORT |
| ITOT · iShares Trust | 0.01% | 117267 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 22367 SH | 2026年8月8日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 15559 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2758 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 45244 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 14544 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 500 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 636 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2488906 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6489 SH | 2026年8月8日 | 每日 |